CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: Possible mechanism for the switch from innate to acquired immune response

International Immunology

Volumn 11, Issue 3, 1999, Pages 417-426

  Iwata, Satoshi ^a   Yamaguchi, Noriko ^a   Munakata, Yasuhiko ^a   Ikushima, Hideto ^a   Lee, James F ^a   Hosono, Osamu ^b   Schlossman, Stuart F ^a   Morimoto, Chikao ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

CD26; Dipeptidyl peptidase IV; Rantes; Transendothelial migration; chemokine

Indexed keywords

CHEMOKINE; DIPEPTIDYL PEPTIDASE IV; RANTES;

ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE MIGRATION; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032992914     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/11.3.417     Document Type: Article

References (40)

1. Fox, D. A., Hussey, R. E., Fitzgerald, K. A., Acuto, O., Poole, C., Palley, L., Daley, J. F., Schlossman, S. F. and Reinherz, E. L. 1984. Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. J. Immunol. 133:1250.
2. Morimoto, C., Torimoto, Y., Levinson, G., Rudd, C. E., Schrieber, M., Dang, N. H., Letvin, N. L. and Schlossman, S. F. 1989. 1F7, a novel cell surface molecule, involved in helper function of CD4 cells. J. Immunol. 143:3430.
3. Torimoto, Y., Dang, N. H., Tanaka, T., Prado, C., Schlossman, S. F. and Morimoto, C. 1992. Biochemical characterization of CD26 (dipeptidyl peptidase IV): functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies. Mol. Immunol. 29:183.
4. Hegen, M., Niedobitek, G., Klein, C. E., Stein, H. and Fleisher, B. 1990. The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity. J. Immunol. 144:2908.
5. Yaron, A. and Naider, F. 1993. Proline-dependent structural and biological properties of peptides and proteins. Crit. Rev. Biochem. Mol. Biol. 28:31.
6. Dang, N. H., Torimoto, Y., Deusch, K., Schlossman, S. F. and Morimoto, C. 1990. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CDS and CD2 pathways. J. Immunol. 144:4092.
7. Tanaka, T., Kameoka, J., Yaron, A., Schlossman, S. F. and Morimoto, C. 1993. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc. Natl Acad. Sci. USA 90:4586.
8. Tanaka, T., Camerini, D., Seed, B., Torimoto, Y., Dang, N. H., Kameoka, J., Dahlberg, H. N., Schlossman, S. F. and Morimoto, C. 1992. Cloning and functional expression of the T cell activation antigen CD26. J. Immunol. 149:481.
9. Torimoto, Y., Dang, N. H., Vivier, E., Tanaka, T., Schlossman, S. F. and Morimoto, C. 1991. Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. J. Immunol. 147:2514.
10. Kameoka, J., Tanaka, T., Nojima, Y., Schlossman, S. F. and Morimoto, C. 1993. Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science 261:466.
11. Morrison, M. E., Vijayasaradhi, S., Engelstein, D., Albino, A. P. and Houghtoni, A. N. 1993. A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase. J. Exp. Med. 177:1135.
12. Dong, R.-P., Kameoka, J., Hegen, M., Tanaka, T., Xu, Y., Schlossman, S. F. and Morimoto, C. 1996. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J. Immunol. 156:1349.
13. Mackay, C. R. 1996. Chemokine receptors and T cell chemotaxis. J. Exp. Med. 184:799.
14. Masuyama, J., Bermen, J. S., Cruikshank, W. W., Morimoto, C. and Center, D. M. 1992. Evidence for recent as well as long term activation of T cells migrating through endothelial cell monolayers in vitro. J. Immunol. 148:1367.
15. + T cells that exhibit a transendothelial migratory capacity. J. Immunol. 154:3062.
16. Roth, S. J., Carr, M. W. and Springer, T. A. 1995. C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-gamma inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes. Eur. J. Immunol. 25:3482.
17. Qin, S., LaRosa, G., Campbell, J. J., Smith-Heath, H., Kassam, N., Shi, X., Zeng, L., Butcher, E. C. and Mackay, C. R. 1996. Expression of monocyte chemoattractant protein-1 and interleukin-8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential. Eur. J. Immunol. 26:640.
18. Nakao, H., Eguchi, K., Kawakami, A., Migita, K., Otsubo, T., Ueki, Y., Shimomura, C., Tezuka, H., Matsunaga, M., Maeda, K. and Nagataki, S. 1989. Increment of Tal positive cells in peripheral blood from patients with rheumatoid arthritis. J. Rheumatol. 16:904.
19. Hafler, D. A., Fox, D. A., Manning, M. E., Schlossman, S. F., Reinherz, E. L. and Weiner, H. L. 1985. In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N. Engl. J. Med. 312:1405.
20. Baggiolini, M., Dewald, B. and Moser, B. 1994. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv. Immunol. 55:97.
21. + T cells. Science 270:1811.
22. Oravecz, T., Pall, M. and Norcross, M. A. 1996. Beta-chemokine inhibition of monocytotropic HIV-1 infection. Interference with a postbinding fusion step. J. Immunol. 157:1329.
23. Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Di Marzio, P., Marmon, S., Sutton, R. E., Hill, C. M., Davis, C. B., Peiper, S. C., Schall, T. J., Littman, D. R. and Landau, N. R. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661.
24. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667.
25. Bates, P. 1996. Chemokine receptors and HIV-1: an attractive pair? Cell 86:1.
26. Doranz, B. J., Rucker, J., Yi, Y., Smyth, R. J., Samson, M., Peiper, S. C., Parmentier, M., Collman, R. G. and Doms, R. W. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149.
27. Tanaka, T., Duke-Cohan, J. S., Kameoka, J., Yaron, A., Lee, I., Schlossman, S. F. and Morimoto, C. 1994. Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV. Proc. Natl Acad. Sci. USA 91:3082.
28. Schall, T. J., Jongstra, J., Dyer, B. J., Jorgensen, J., Clayberger, C., Davis, M. M. and Krensky, A. M. 1988. A human T cell-specific molecule is a member of a new gene family. J. Immunol. 141:1018.
29. De Meester, I., Vanhoof, G., Lambeir, and A.-M. and Scharpe, S. 1996. Use of immobilized adenosine deaminase (EC 3.5.4.4) for the rapid purification of native human CD26/dipeptidyl peptidase IV (EC 3.4.14.5). J. Immunol. Methods 189:99.
30. Mentlein, R. 1988. Proline residues in the maturation and degradation of peptide hormones and neuropeptides. FEBS Lett. 234:251.
31. Oravecz, T., Pall, M., Roderiquez, G., Gorrel, M. D., Ditto, M., Nguyen, N. Y., Boykins, R., Unsworth, E. and Norcross., M. A. 1997. Regulation of the receptor specificity and formation of the chemokine RANTES (regulated on activation, normal t cell expressed and secreted) by dipeptydyl peptidase IV (CD26)-mediated cleavage. J. Exp. Med. 186: 1865.
32. Proudfoot, A. E. I., Power, C. A., Hoogewerf, A. J., Montjovent, M.-O., Borlat, F., Offord, R. E. and Wells, T. N. C. 1996. Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. J. Biol. Chem. 271:2599.
33. Gong, J.-H., Uguccioni, M., Dewald, B., Baggiolini, M. and Clark-Lewis, I. 1996. RANTES and MCP-3 antagonists bind multiple chemokine receptors. J. Biol. Chem. 271:10521.
34. Clark-Lewis, I., Kim, K.-S., Rajarathnam, K., Gong, J.-H., Dewald, B., Moser, B., Baggiolini, M. and Sykes, B. D. 1995. Structure-activity relationships of chemokines. J. Leukocyte Biol. 57:703.
35. Premack, B. A. and Schall, T. J. 1996. Chemokine receptors: gateways to inflammation and infection. Nature Med. 11:1174.
36. Proost, P., De Meester, I., Schols, D., Struyf, S., Lambeir, A.-M., Wuyts, A., Opdenakker, G., De Clercq, E., Scharpe, S. and Van Damme, J. 1998. Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J Biol. Chem. 273:7222.
37. Struyf, S., De Meester, I., Scharpe, S., Lenaerts, J. P., Menten, P., Wang, J. M., Proost, P. and Van Damme, J. 1998. Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor. Eur. J. Immunol. 28:1262.
38. Arenzana-Seisdedos, F., Virelizier, J.-L., Rousset, D., Clark-Lewis, I., Loetscher, P., Moser, B. and Baggioloni, M. 1996. HIV blocked by chemokine antagonist. Nature 383:400.
39. Noso, N., Sticherling, M., Bartels, J., Mallet, A. I., Christophers, E. and Schröder, J.-M. 1996. Identification of an N-terminally truncated form of the chemokine RANTES and granulocyte-macrophage colony-stimulating factor as major eosinophil attractants released by cytokine-stimulated dermal fibroblasts J. Immunol. 156:1946.
40. Morimoto, C., Lord, C. I., Zhang, C., Duke-Cohan, J. S., Letvin, N. L. and Schlossman, S. F. 1994. Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis. Proc. Natl Acad. Sci. USA 91:9960.